This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
[Tc-99m]-Medronate (2017-09-22)
- Starting date:
- September 22, 2017
- Posting date:
- October 6, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- Hospitals, Healthcare Professionals, General Public
- Identification number:
- RA-64810
Affected products
[Tc-99m]-Medronate
Reason
The sterility may be out of specification in the affected lots.
Depth of distribution
3 Hospitals located in Hamilton, Ontario, Canada
Affected products
[Tc-99m]-Medronate
DIN, NPN, DIN-HIM
No market authorization
Dosage form
Liquid
Strength
14.30, 3.39, and 4.87 GBq
12.39 and 8.66 GBq
Lot or serial number
M-170830MDP-1, M-170830MDP-2,
M-170830MDP-3
M-170905MDP-1, M-170905MDP-2
Companies
- Recalling Firm
-
Centre for Probe Development and Commercialization (CPDC)
1280 Main St. W. NRB-A316
Hamilton
L8S 4K1
Ontario
CANADA
- Marketing Authorization Holder
-
Not Applicable